Title | Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. |
Publication Type | Journal Article |
Year of Publication | 2012 |
Authors | Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan G, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park I-H, Friedman BA, Daley GQ, Wyllie DJA, Hardingham GE, Wilmut I, Finkbeiner S, Maniatis T, Shaw CE, Chandran S |
Journal | Proc Natl Acad Sci U S A |
Volume | 109 |
Issue | 15 |
Pagination | 5803-8 |
Date Published | 2012 Apr 10 |
ISSN | 1091-6490 |
Keywords | Adult, Cell Differentiation, Detergents, DNA-Binding Proteins, Female, Fibroblasts, Humans, Induced Pluripotent Stem Cells, Male, Middle Aged, Motor Neurons, Mutation, Organ Specificity, Solubility, TDP-43 Proteinopathies |
Abstract | Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening. |
DOI | 10.1073/pnas.1202922109 |
Alternate Journal | Proc. Natl. Acad. Sci. U.S.A. |
PubMed ID | 22451909 |
PubMed Central ID | PMC3326463 |
Grant List | 089701 / / Wellcome Trust / United Kingdom G0300329 / / Medical Research Council / United Kingdom G0500289 / / Medical Research Council / United Kingdom G0900688 / / Medical Research Council / United Kingdom G0902044 / / Medical Research Council / United Kingdom G0902044(94018) / / Medical Research Council / United Kingdom K08 NS072233 / NS / NINDS NIH HHS / United States MC_G1000733 / / Medical Research Council / United Kingdom R01 NS039074 / NS / NINDS NIH HHS / United States / / Biotechnology and Biological Sciences Research Council / United Kingdom / / Medical Research Council / United Kingdom / / Wellcome Trust / United Kingdom |